ReproCELL Incorporated (TYO:4978)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Research Support Business		2.41B	2.08B	2.02B	1.38B	1.20B
Research Support Business Growth		16.10%	3.07%	46.14%	15.02%	7.12%
Medical Business		564.04M	347.16M	935.51M	853.90M	85.92M
Medical Business Growth		62.47%	-62.89%	9.56%	893.81%	8.35%
Total		2.98B	2.43B	2.95B	2.23B	1.29B
Total Growth		22.74%	-17.83%	32.16%	73.72%	7.20%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan		48.31M	904.05M	1.50B	1.25B	558.34M
Japan Growth		-94.66%	-39.68%	20.00%	123.69%	43.93%
United States		139.94M	897.11M	805.13M	508.85M	445.48M
United States Growth		-84.40%	11.42%	58.22%	14.23%	-2.55%
United Kingdom		11.34M	575.81M	549.07M	400.54M	222.69M
United Kingdom Growth		-98.03%	4.87%	37.08%	79.86%	-25.78%
India		-	49.85M	100.29M	76.21M	59.77M
India Growth		-	-50.29%	31.60%	27.49%	9.01%
Total		199.59M	2.43B	2.95B	2.23B	1.29B
Total Growth		-91.78%	-17.83%	32.16%	73.72%	7.20%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error